| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |